Biotecnologia da Biodiversidade: Desafios Regulatórios e Institucionais
Summary
The report analyzes the intersection of biotechnology, biodiversity, and bioeconomy in Brazil, arguing that while the country possesses immense biological potential, a complex and unpredictable regulatory environment—specifically the Access and Benefit-Sharing (ABS) framework—stifles innovation. It highlights that the SisGen system is cumbersome, benefit-sharing mechanisms are underperforming, and institutional fragmentation across ministries hinders a cohesive national strategy. The authors advocate for the explicit inclusion of 'biodiversity biotechnology' in the PNDBio to transform biological assets into sustainable economic value, especially in the Amazon.
Key insights
- The regulatory framework for biodiversity, specifically the Access and Benefit-Sharing (ABS) regime, is the primary source of complexity and legal insecurity for biotechnology in Brazil, more so than general biotechnology or bioeconomy regulations.
- Benefit-sharing results are significantly lower than expected; however, in the Amazon, a high proportion of biodiversity-derived products involve identifiable traditional knowledge (CTA), meaning direct sharing with local communities is more frequent there than nationally.
- The National Management System for Genetic Heritage and Associated Traditional Knowledge (SisGen) is characterized by a non-intuitive interface and excessive data requirements, creating compliance barriers for startups and small businesses.
- CGen Resolution No. 47/2025, which creates reference lists for traditional knowledge, may increase bureaucracy and legal uncertainty by potentially requiring prior informed consent for a larger portion of academic research.
- The National Benefit-Sharing Fund (FNRB) has been largely ineffective, collecting approximately R$ 9.9 million between 2020 and February 2025, with resources only beginning to be distributed in June 2025 via the 'Guardiões da Sociobiodiversidade' award.
- International cooperation is hindered by the requirement for foreign companies to have a national representative and Brazil's lack of integration with the Nagoya Protocol's ABS Clearing-House (ABSCH).
- The requirement for a Material Transfer Term (TTM) for sending genetic samples abroad delays scientific research and the publication of new species, potentially leading to 'jurisdiction shopping'.
- There is a significant institutional disconnect between ministries; the MMA focuses on sociobiodiversity, while MDIC and Mapa emphasize bioindustry and biomass, respectively, leading to a fragmented environment for biodiversity biotechnology.
- The National Bioeconomy Development Plan (PNDBio) currently fails to explicitly include biodiversity biotechnology in its strategic missions, risking a reduction of the bioeconomy agenda to biomass and bioenergy.
- Financial barriers persist for biotechnology startups in health, pharmaceuticals, and cosmetics, which face more limited access to specialized investors compared to the agrotech sector.
Cite the original document
- APA
- Climate Policy Initiative (n.d.). Biotecnologia da Biodiversidade: Desafios Regulatórios e Institucionais. https://www.climatepolicyinitiative.org/wp-content/uploads/2025/10/Biotecnologia-da-Biodiversidade.pdf
- Chicago
- Climate Policy Initiative. Biotecnologia da Biodiversidade: Desafios Regulatórios e Institucionais. n.d. https://www.climatepolicyinitiative.org/wp-content/uploads/2025/10/Biotecnologia-da-Biodiversidade.pdf.
- Wikipedia
- {{cite report |author=Climate Policy Initiative |title=Biotecnologia da Biodiversidade: Desafios Regulatórios e Institucionais |url=https://www.climatepolicyinitiative.org/wp-content/uploads/2025/10/Biotecnologia-da-Biodiversidade.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}
- BibTeX
- @techreport{climatepolicyinitiativendbiotecnologia, author = {{Climate Policy Initiative}}, title = {{Biotecnologia da Biodiversidade: Desafios Regulatórios e Institucionais}}, institution = {Climate Policy Initiative}, url = {https://www.climatepolicyinitiative.org/wp-content/uploads/2025/10/Biotecnologia-da-Biodiversidade.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }
Full text
Collected · Record updated